










































Uterine DCs are essential for pregnancy
Citation for published version:
Pollard, JW 2008, 'Uterine DCs are essential for pregnancy' Journal of Clinical Investigation, vol. 118, no.
12, pp. 3832-5. DOI: 10.1172/JCI37733
Digital Object Identifier (DOI):
10.1172/JCI37733
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Clinical Investigation
Publisher Rights Statement:
Copyright © 2008, American Society for Clinical Investigation
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
commentaries

























































zyme. J. Clin. Endocrinol. Metab. 88:2194–2205.
  21. Yuan, W., and Lopwz Bernal, A. 2007. Cyclic AMP 
signalling pathways in the regulation of uterine 






on Akt activation. J. Biol. Chem. 280:38276–38289.
  23. Noble, D. 2006. The music of life: biology beyond the 
genome. Oxford University Press. Oxford, United 
Kingdom. 153 pp.
Uterine DCs are essential for pregnancy
Jeffrey W. Pollard
Department of Developmental and Molecular Biology, Department of Obstetrics and Gynecology and Women’s Health,  




























maternal  immunologic  tolerance of  the 
fetus, which expresses foreign transplanta-
tion antigens. This latter requirement poses 
a  significant  immunological  challenge, 




























of  implantation  and  continue  to  climb 
























































Decidual angiogenesis  











































uDCs regulate decidualization. At the beginning of pregnancy, the ovarian steroid hormones 17β-estradiol (E2) and progesterone (P4) stimulate 
synthesis of growth factors from the uterine epithelium, including CSF-1 and leukemia inhibitor factor (LIF). LIF, acting on the luminal epithelium, 
is essential for blastocyst implantation and subsequent decidualization. CSF-1 recruits and regulates uterine macrophages, while also influencing 
the biology of uDCs. In addition, CSF-1 acts on decidual cells and trophoblastic cells (not shown). Macrophages play a largely immune role at this 
stage, while, as Plaks et al. (7) show in their current study in this issue of the JCI, uDCs are required for efficient decidualization. This decidualiza-
tion process involves transformation of stromal cells into epithelioid-type cells at the site of blastocyst implantation on the antimesometrial side of 
the uterus. The decidual cells grow in an arc, via rapid proliferation and transformation, to surround the implanting embryo. After implantation is 
complete, the blastocyst is entirely surrounded by a primary decidual zone of polyploid cells and a secondary diploid decidual zone. Vasculariza-
tion commences on the mesometrial side of the uterus via the growth of vascular sprouts from the uterine artery into the decidua, which results 
in vessels with large, dilated lumens through which maternal blood bathes the decidual nodule. As Plaks et al. report, uDCs located in the outer 
layers of the decidua regulate this vascularization in part through their synthesis of TGF-β1 and sFLT1. Ablation of uDCs results in a failure of 
decidual growth and resorption of the embryo, showing that uDCs are essential for a successful pregnancy.
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targeted gene approach, the authors found 



































Placentation is regulated by the 
interplay of innate immune cells







CSF-1,  IL-11,  IL-15,  and  TNF-α,  often 
under the control of estrogen and proges-
terone. While these cells have roles in the 












Proposed roles of uDCs in the regulation of angiogenesis and T cell action at the maternal-fetal 
interface. During pregnancy, monocytes are recruited to the uterus, where they differentiate 
into mature tolerogenic cells such as uDCs, under the influence of CSF-1, GM-CSF, and other 
cytokines (usually IL-4, although this cytokine has not been found in the uterus). uDCs produce 
sFLT1 and TGF-β1, which act to maintain the intricate balance of vascular development: sFLT1 
modulates the actions of VEGF, and TGF-β1 influences endothelial cell viability and vascular 
maturation. This fine-tuning of angiogenesis is required for decidualization and embryo implanta-
tion. In addition, other studies have shown that TGF-β1 is presented by DCs at their surface on 
αvβ8 integrin. TGF-β1 suppresses cytotoxic CD8+ T cell function and promotes the development 
of Tregs. These data suggest that in addition to their role in decidual development, as shown in 
the present study by Plaks et al (7), uDCs also play a role in immunoregulation. Together, these 
dual functions of uDCs contribute to successful implantation and the progression of an allogeneic 
pregnancy. This whole process is further coordinated during implantation and decidualization 
by the uterine synthesis of the growth factors VEGF and CSF-1 under the control of the ovarian 
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Tumor metabolism: cancer cells  
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anhydrase  IX  (8); MCT4, which  encodes 
monocarboxylate  transporter  4  (9);  and 
NHE1, which encodes  sodium-hydrogen 
exchanger 1 (10).
Metabolic symbiosis
In this issue of the JCI, the elegant article by 
Sonveaux, Dewhirst, et al. makes a major con-
tribution to the field of cancer biology (11). 
